Related Experiment Video

Updated: May 1, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.6K

The nature and prognosis of severe cryptogenic chronic active hepatitis

A J Czaja1, H A Carpenter, P J Santrach

  • 1Division of Gastroenterology and Internal Medicine, Mayo Clinic, Rochester, Minnesota.

Gastroenterology
|June 1, 1993
PubMed

Insights

Severe cryptogenic hepatitis closely resembles autoimmune hepatitis in clinical presentation, genetic markers, and response to corticosteroids. This suggests it may be an autoimmune condition not identified by standard tests.

Area of Science:

  • Hepatology
  • Immunology
  • Genetics

Background:

  • Cryptogenic chronic active hepatitis (CCA H) is a liver disease of uncertain etiology, potentially autoimmune or viral.
  • Distinguishing CCA H from other liver diseases is crucial for appropriate management.
  • This study investigates the characteristics of severe CCA H.

Purpose of the Study:

  • To define the clinical features of severe CCA H.
  • To analyze the human leukocyte antigen (HLA) phenotype in CCA H.
  • To assess the response to corticosteroid therapy in CCA H and compare it with autoimmune and viral hepatitis.

Main Methods:

  • Comparison of 12 CCA H patients with 94 autoimmune hepatitis (AIH) and 30 chronic viral hepatitis (CVH) patients.
  • Evaluation of clinical, laboratory, histological, and HLA phenotype data.
  • Assessment of remission and treatment failure rates during corticosteroid therapy.

Main Results:

  • CCA H patients were clinically and histologically indistinguishable from AIH patients.
  • No significant differences in HLA B8, DR3, or A1-B8-DR3 phenotypes were observed between CCA H and AIH.
  • CCA H and AIH showed similar remission and treatment failure rates with corticosteroids, unlike CVH patients who had distinct features.

Conclusions:

  • Severe CCA H shares clinical, genetic, and therapeutic similarities with AIH.
  • CCA H may represent an autoimmune hepatitis variant lacking conventional immunoserological markers.
  • Further research into the immunopathogenesis of CCA H is warranted.
Abstract

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.4K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

7.2K

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
906
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80%...
26
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
30